title: Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries.
abstract: The formylpeptide receptor (FPR1) and formylpeptide-like 1 receptor (FPR2) are G protein-coupled receptors that are linked to acute inflammatory responses, malignant glioma stem cell metastasis, and chronic inflammation. Although several N-formyl peptides are known to bind to these receptors, more selective small-molecule, high-affinity ligands are needed for a better understanding of the physiologic roles played by these receptors. High-throughput assays using mixture-based combinatorial libraries represent a unique, highly efficient approach for rapid data acquisition and ligand identification. We report the superiority of this approach in the context of the simultaneous screening of a diverse set of mixture-based small-molecule libraries. We used a single cross-reactive peptide ligand for a duplex flow cytometric screen of FPR1 and FPR2 in color-coded cell lines. Screening 37 different mixture-based combinatorial libraries totaling more than five million small molecules (contained in 5,261 mixture samples) resulted in seven libraries that significantly inhibited activity at the receptors. Using positional scanning deconvolution, selective high-affinity (low nM K(i)) individual compounds were identified from two separate libraries, namely, pyrrolidine bis-diketopiperazine and polyphenyl urea. The most active individual compounds were characterized for their functional activities as agonists or antagonists with the most potent FPR1 agonist and FPR2 antagonist identified to date with an EC₅₀ of 131 nM (4 nM K(i)) and an IC₅₀ of 81 nM (1 nM K(i)), respectively, in intracellular Ca²⁺ response determinations. Comparative analyses of other previous screening approaches clearly illustrate the efficiency of identifying receptor selective, individual compounds from mixture-based combinatorial libraries.
authors.affiliation: Torrey Pines Institute for Molecular Studies, San Diego, California, USA.
authors.forename: Clemencia
authors.initials: C
authors.lastname: Pinilla
authors.forename: Bruce S
authors.initials: BS
authors.lastname: Edwards
authors.forename: Jon R
authors.initials: JR
authors.lastname: Appel
authors.forename: Tina
authors.initials: T
authors.lastname: Yates-Gibbins
authors.forename: Marc A
authors.initials: MA
authors.lastname: Giulianotti
authors.forename: Jose L
authors.initials: JL
authors.lastname: Medina-Franco
authors.forename: Susan M
authors.initials: SM
authors.lastname: Young
authors.forename: Radleigh G
authors.initials: RG
authors.lastname: Santos
authors.forename: Larry A
authors.initials: LA
authors.lastname: Sklar
authors.forename: Richard A
authors.initials: RA
authors.lastname: Houghten
mesh_terms: D000596:Amino Acids / Q000737:chemistry; D000818:Animals; D002118:Calcium / Q000378:metabolism; D045744:Cell Line, Tumor; D054659:Diketopiperazines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry; D057166:High-Throughput Screening Assays; D006801:Humans; D010455:Peptides / Q000737:chemistry; D057786:Peptidomimetics / Q000737:chemistry; D011759:Pyrrolidines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D051381:Rats; D044042:Receptors, Formyl Peptide / Q000819:agonists* / Q000037:antagonists & inhibitors*; D054852:Small Molecule Libraries / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D013237:Stereoisomerism
chemical_list: D000596:Amino Acids; D054659:Diketopiperazines; C469986:FPR1 protein, human; D010455:Peptides; D057786:Peptidomimetics; D011759:Pyrrolidines; D044042:Receptors, Formyl Peptide; D054852:Small Molecule Libraries; D002118:Calcium